Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
The current price of EMBC is $8.93 USD — it has increased by +0.9% in the past 24 hours. Watch Embecta stock price performance more closely on the chart.
What is Embecta stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Embecta stocks are traded under the ticker EMBC.
Is Embecta stock price growing?▼
EMBC stock has risen by +1.02% compared to the previous week, the month change is a -1.54% fall, over the last year Embecta has showed a -26.14% decrease.
What is Embecta market cap?▼
Today Embecta has the market capitalization of 528.83M
When is the next Embecta earnings date?▼
Embecta is going to release the next earnings report on May 08, 2026.
What were Embecta earnings last quarter?▼
EMBC earnings for the last quarter are 0.71 USD per share, whereas the estimation was 0.67 USD resulting in a +5.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Embecta revenue for the last year?▼
Embecta revenue for the last year amounts to 2.16B USD.
What is Embecta net income for the last year?▼
EMBC net income for the last year is 190.8M USD.
Does Embecta pay dividends?▼
Yes, EMBC dividends are paid quarterly. The last dividend per share was 0.15 USD. As of today, Dividend Yield (FWD)% is 6.72%.
How many employees does Embecta have?▼
As of April 07, 2026, the company has 2,000 employees.